Correction: Diagnostic performance of plasma pTau217, pTau181, Aβ1‑42 and Aβ1‑40 in the LUMIPULSE automated platform for the detection of Alzheimer disease

Схожі ресурси

• Correction: Diagnostic performance of plasma pTau217, pTau181, Aβ1‑42 and Aβ1‑40 in the LUMIPULSE automated platform for the detection of Alzheimer disease
  за авторством: Javier Arranz, та інші
  Опубліковано: (2024-07-01)
• Prospective evaluation of plasma pTau217 stability for the detection of Alzheimer’s disease in a tertiary memory clinic
  за авторством: Javier Arranz, та інші
  Опубліковано: (2025-07-01)
• Exploring the ability of plasma pTau217, pTau181 and beta-amyloid in mirroring cerebrospinal fluid biomarker profile of Mild Cognitive Impairment by the fully automated Lumipulse® platform
  за авторством: Marcella Catania, та інші
  Опубліковано: (2025-01-01)
• Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology
  за авторством: Daniel J. Figdore, та інші
  Опубліковано: (2024-01-01)
• Evaluating the real-world performance of plasma pTau217 and pTau181 in a Southeast Asian tertiary memory clinic
  за авторством: Yi Jayne Tan, та інші
  Опубліковано: (2026-03-01)